CN104740558A - Traditional Chinese medicine composition for treating gallstones with cholecystitis - Google Patents
Traditional Chinese medicine composition for treating gallstones with cholecystitis Download PDFInfo
- Publication number
- CN104740558A CN104740558A CN201410606877.5A CN201410606877A CN104740558A CN 104740558 A CN104740558 A CN 104740558A CN 201410606877 A CN201410606877 A CN 201410606877A CN 104740558 A CN104740558 A CN 104740558A
- Authority
- CN
- China
- Prior art keywords
- parts
- cholecystitis
- chinese medicine
- medicine composition
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating gallstones with cholecystitis. The traditional Chinese medicine composition for treating gallstones with cholecystitis comprises the following raw materials in parts by weight: 24-26 parts of pericarpium citri reticulatae viride, 9-11 parts of dandelion, 19-21 parts of rabdosia lophanthide, 9-11 parts of curcuma aromatica, 9-11 parts of nauclea officinalis, 14-16 parts of armillaria tabescens, 5-7 parts of tibetan saxifrage, 5-7 parts of pogonatum microstomum, 9-11 parts of corydalis tuber, 9-11 parts of ginger and 4-6 parts of liquorice. The traditional Chinese medicine composition for treating gallstones with cholecystitis disclosed by the invention aims at the etiology and pathogenesis of gallstones with cholecystitis, is based on the traditional Chinese medicine therapy, takes pericarpium citri reticulatae viride as a monarch medicine, takes dandelion, rabdosia lophanthide, curcuma aromatica and nauclea officinalis as minister medicines, takes liquorice as a guide medicine, fundamentally removes the etiology while improving the symptoms of patients, and has a total effective rate of 89%.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis.
Background technology
Cholecystitis is the gallbladder inflammatory lesion that bacterial infection or chemical irritation (bile component change) cause, and is the commonly encountered diseases of gallbladder.The commonly encountered diseases of cholecystitis is because being cholelithiasis, and account for 70% of cholecystitis sickness rate, groups of people are without the obvious cause of disease.Its pathological change is gallbladder wall cell infiltration, and proliferation of fibrous tissue, makes thickening of capsule wall of gallbladder, fibrosis, thus affects the contractile function of gallbladder, and bile is discharged not smooth, not even bilification.
The traditional Chinese medical science thinks that gallbladder is " fu-viscera with clear juice ", invests liver under being positioned at right flank, and with liver phase the exterior and the interior, defeated bile and do not pass digesting and absorbing the essence of foodstuff, functionally to fall behavior suitable with logical.Any factor, when having influence on " in clear " and " lead to and fall row " of gallbladder, can be fallen ill.Following factors can cause " in clear " of gallbladder and " lead to and fall row ": (1) disorder of emotion: liver controlling conveyance and dispersion, property happiness bar reach, dredge promoting the circulation of QI machine, the secretion of bile, conveying, storage, excretion are normally carried out, to help taste to receive digesting and absorbing the essence of foodstuff, excessive anxiety and rage, feelings will are smooth, cause depression of liver-QI, catharsis is not normal, thus make that bileization is raw, conveying, abevacuation and causing a disease; (2) eating and drinking without temperance: hungry full variable, surfeit delicious food savoury, pungent pure wine etc., cause transformation and transportation of the spleen and stomach not normal, endogenous damp formation, hinders mechanism of qi, strongly fragrant and heat-transformation, hot and suffocatingly accumulates steaming mutually with turbid damp, and gallbladder internal organs loses and falls in leading to and fall ill; (3) ascarid disturbs: ascarid disturbs, make QI depression of the liver and gallbladder, catharsis is neglected one's duty, and bile excretion is smooth, heat-transformation for a long time, damp and hotly accumulates steaming, forms cholelithiasis; (4) exopathogen invasion and attack: cold temperature is uncomfortable, being invaded by exogenous pathogen, few positive disorder of QI movement, gallbladder internal organs loses and falls in logical.
The pathogenesis of primary disease is generally initial with QI depression of the liver and gallbladder.Various paathogenic factor above, can cause depression of liver-QI, courage is obstructed, abdominal and hypochondriac pain; Perverse and unreasonable manner violates stomach, therefore nausea and vomiting; Transporting and transforming function of the spleen and stomach is not normal, retention of damp-heat in the interior, then become dampness-heat in the liver and gallbladder, thus heating or alternate attack of chill and fever, bitter taste.Damp and hot friendship is steamed, and forces bile excessive, then skin, white of the eye jaundice.Abdominal and hypochondriac pain, heating are the primary symptoms of cholelithiasis, and developing into certain phase can occur jaundice.If accumulation of heat does not fall apart, then putrefaction of blood and muscle, wine forms pus.Pyretic toxicity fire-transformation, invade nutrient blood or in disturb gods, very then " exhaustion of YIN " ", YANG-depletion ".
Summary of the invention
The technical problem that basic background technology exists, the present invention proposes a kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis, the etiology and pathogenesis of cholecystitis is merged for cholelithiasis, according to the method for tcm syndrome differentiation and treatment, take Pericarpium Citri Reticulatae Viride as monarch drug, with Herba Taraxaci, Herba Rabdosiae Lophanthoidis, Radix Curcumae and Lignum et Radix Naucleae for ministerial drug, with Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Saxifragae przewalskii, Pogonatum microstomum (schwaegr) Brid, Rhizoma Corydalis and Rhizoma Zingiberis Recens for adjuvant drug, with Radix Glycyrrhizae for making medicine, while improving patients symptomatic, fundamentally remove the cause of disease, total effective rate can reach 89%.
A kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis that the present invention proposes, its raw material comprises by weight: Pericarpium Citri Reticulatae Viride 24-26 part, Herba Taraxaci 9-11 part, Herba Rabdosiae Lophanthoidis 19-21 part, Radix Curcumae 9-11 part, Lignum et Radix Naucleae 9-11 part, Armillaria mella tabescens (Scop.ex Fr.) Sing. 14-16 part, Herba Saxifragae przewalskii 5-7 part, Pogonatum microstomum (schwaegr) Brid 5-7 part, Rhizoma Corydalis 9-11 part, Rhizoma Zingiberis Recens 9-11 part, Radix Glycyrrhizae 4-6 part.
Pericarpium Citri Reticulatae Viride, the dry young fruit of rutaceae orange and variety thereof or the peel of immature fruit.Collecting the young fruit from falling the 5-6 month, drying, practise and claiming " FTUCTUS CITRI IMMATURI " or " Pericarpium Citri Reticulatae Viride "; Gather the 7-8 month green fruit, on peel, vertical profile becomes pintongs to base portion, eliminates flesh lobe, dries, and practises and claims " Sihuaqingpi ".Bitter in the mouth is pungent, warm in nature, enters liver, gallbladder, stomach warp.There is the effect that soothing the liver dispelling the stagnated QI, removing food stagnancyization are stagnant.For costa sternales gastral cavity distending pain, acute mastitis, colic, stagnation of QI due to dyspepsia.
Herba Taraxaci, Dandelion Compositae herbaceos perennial.Sweet in the mouth, hardship, cold in nature, return stomach, Liver Channel.There is heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, effect of inducing diuresis for treating stranguria syndrome.For furuncle swelling toxin, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.Modern pharmacology confirms, containing multiple health-nutrition compositions such as taraxol, taraxacin, choline, organic acid, inulin in Herba Taraxaci plant, has the effects such as diuresis, cathartic, jaundice eliminating subcutaneous ulcer, function of gallbladder promoting.
Herba Rabdosiae Lophanthoidis is the herb of labiate Rabdosia lophanthoides.Summer, autumn gather.Bitter in the mouth, cold in nature, return gallbladder meridian, Liver Channel, large intestine channel.There is effect of heat-clearing and toxic substances removing, dampness removing jaundice eliminating, dissipating blood stasis for subsidence of swelling.Cure mainly damp and hot yellow cellulitis, cholecystitis, has loose bowels, and skin ulcer swells, traumatic pain.
Radix Curcumae is the dried root of zingiberaceous plant RADIX CURCUMAE, Rhizoma Curcumae Longae, Guangxi zedoary or Rhizoma Curcumae.The above two practise title " RADIX CURCUMAE " and " Radix Curcuma " respectively, and all the other are practised by character difference and claim " osmanthus Radix Curcumae " or " green filament Radix Curcumae ".Winter, stem and leaf was excavated after withering, and removing silt and radicula, steam or boil to the saturating heart, dry.Acrid in the mouth, hardship, cool in nature, GUIXIN warp, gallbladder meridian, Liver Channel.There is regulating qi to disperse stagnation, heart fire-clearing upset-relieving, effect of promoting the function of the gallbladder to alleviate jaundice.For amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine.
Lignum et Radix Naucleae is Rubiaceae Nauclea plant ebony, is used as medicine with branch, dry, skin.The whole year can adopt.Clean, section, using fresh herb or dry.Bitter in the mouth, cold in nature.Return gallbladder meridian, lung meridian, large intestine channel, urinary bladder channel.There is heat-clearing and toxic substances removing, the function of reducing swelling and alleviating pain.For cold, fever, acute tonsillitis, pharyngolaryngitis, bronchitis, pneumonia, urinary system infection, enteritis, dysentery, cholecystitis; Mastitis are controlled in external, carbuncle furuncle abscess.
Armillaria mella tabescens (Scop.ex Fr.) Sing. is the mycelium of Bai Mo section fungus armillariella tabescens.Bitter in the mouth, cold in nature, return gallbladder meridian, Liver Channel.Cure mainly cholecystitis, hepatitis, appendicitis, otitis media etc.
Herba Saxifragae przewalskii is the herb of the logical greatly Herba Saxifragae of saxifragaceae plant.Summer gathers, and dries for subsequent use.Bitter in the mouth, cold in nature, return stomach warp, gallbladder meridian, Liver Channel.There is liver heat removing gallbladder-heat, the function of stomach invigorating.Cure mainly hepatitis, cholecystitis, influenza is had a fever, dyspepsia.
Pogonatum microstomum (schwaegr) Brid is the herb of pigeon-wheat section plant Pogonatum microstomum (schwaegr) Brid.Acrid in the mouth, cool in nature, return gallbladder meridian, Liver Channel.There is 'Shugan Lidan '; Effect of calculus pain relieving.Cure mainly gallbladder JISHI etc.
Rhizoma Corydalis is the dry tuber of papaveraceae plant corydalis.Excavate when early summer stem and leaf is withered, removing fibrous root, cleans, and puts in boiling water and boils to during just without the white heart, take out, dry.Acrid in the mouth, hardship, warm in nature.Return liver, spleen channel.Can invigorate blood circulation, promoting the circulation of QI, pain relieving.For the breast side of body, epigastric pain, amenorrhea dysmenorrhea, postpartum stagnation, tumbling and swelling.
Rhizoma Zingiberis Recens is the fresh rhizome of ginger Rhizoma Zingiberis Recens.Autumn, season in winter two excavate, and removing fibrous root and silt, medicinal is good with old ginger.Acrid in the mouth, slightly warm in nature, return lung, spleen, stomach warp.There is the cold expelling that induces sweat, warming middle-JIAO to arrest vomiting, preventing phlegm from forming and stopping coughing.For anemofrigid cold, gastrofrigid vomiting, cold-phlegm is coughed.
Radix Glycyrrhizae, property is put down, and sweet in the mouth, returns stomach warp, lung meridian, spleen channel.There is heat-clearing and toxic substances removing, nourishing the lung to arrest cough, effect of coordinating the actions of various ingredients in a prescription.Cure mainly laryngopharynx swelling and pain, cough, weakness of the spleen and stomach, taste-blindness rate, hepatitis, hysteria, carbuncle furuncle and phyma poison, medicine and alimentary toxicosis.
Preferably, the weight ratio of Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Saxifragae przewalskii, Pogonatum microstomum (schwaegr) Brid, Rhizoma Corydalis and Rhizoma Zingiberis Recens is 14.3-15.6:5.2-6.7:5.5-6.3:9.2-10.1:9.4-10.5.
Preferably, its raw material comprises by weight: Pericarpium Citri Reticulatae Viride 24.5-25.5 part, Herba Taraxaci 9.7-10.5 part, Herba Rabdosiae Lophanthoidis 19.3-20.4 part, Radix Curcumae 9.7-10.2 part, Lignum et Radix Naucleae 9.2-10.3 part, Armillaria mella tabescens (Scop.ex Fr.) Sing. 14.3-15.6 part, Herba Saxifragae przewalskii 5.2-6.7 part, Pogonatum microstomum (schwaegr) Brid 5.5-6.3 part, Rhizoma Corydalis 9.2-10.1 part, Rhizoma Zingiberis Recens 9.4-10.5 part, Radix Glycyrrhizae 4.5-5.5 part.
Preferably, its raw material comprises by weight: 25 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 10 parts, Herba Rabdosiae Lophanthoidis 20 parts, Radix Curcumae 10 parts, Lignum et Radix Naucleae 10 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 15 parts, Herba Saxifragae przewalskii 6 parts, Pogonatum microstomum (schwaegr) Brid 6 parts, Rhizoma Corydalis 10 parts, 10 parts, Rhizoma Zingiberis Recens, 5 parts, Radix Glycyrrhizae.
The present invention is directed to the etiology and pathogenesis that cholelithiasis merges cholecystitis, take Pericarpium Citri Reticulatae Viride as monarch drug, soothing the liver dispelling the stagnated QI, removing food stagnancyization are stagnant; With Herba Taraxaci, Herba Rabdosiae Lophanthoidis, Radix Curcumae and Lignum et Radix Naucleae for ministerial drug, assist a ruler in governing a country monarch drug, energy heat-clearing and toxic substances removing, regulating qi to disperse stagnation, dispersing swelling and dissipating binds, resolving depression function of gallbladder promoting; With Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Saxifragae przewalskii, Pogonatum microstomum (schwaegr) Brid, Rhizoma Corydalis and Rhizoma Zingiberis Recens for adjuvant drug, assist monarch drug and ministerial drug on the one hand, further liver heat removing gallbladder-heat, soothing liver-QI, function of gallbladder promoting, calculus, on the other hand monarch drug and ministerial drug excessively strong is relieved inflammation or internal heat, the performance of dampness relaxes, and can stomach invigorating, pain relieving, invigorate blood circulation, promoting the circulation of QI, again with Radix Glycyrrhizae for making medicine, coordinating the actions of various ingredients in a prescription, reduce toxicity, while improving patients symptomatic, fundamentally remove the cause of disease, total effective rate can reach 89%.
Detailed description of the invention
Below, by specific embodiment, technical scheme of the present invention is described in detail.
Embodiment 1
A kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis that the present invention proposes, its raw material comprises by weight: 26 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 9 parts, Herba Rabdosiae Lophanthoidis 21 parts, Radix Curcumae 9 parts, Lignum et Radix Naucleae 11 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 14 parts, Herba Saxifragae przewalskii 7 parts, Pogonatum microstomum (schwaegr) Brid 5 parts, Rhizoma Corydalis 11 parts, 9 parts, Rhizoma Zingiberis Recens, 6 parts, Radix Glycyrrhizae.
Embodiment 2
A kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis that the present invention proposes, its raw material comprises by weight: 24 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 11 parts, Herba Rabdosiae Lophanthoidis 19 parts, Radix Curcumae 11 parts, Lignum et Radix Naucleae 9 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 16 parts, Herba Saxifragae przewalskii 5 parts, Pogonatum microstomum (schwaegr) Brid 7 parts, Rhizoma Corydalis 9 parts, 11 parts, Rhizoma Zingiberis Recens, 4 parts, Radix Glycyrrhizae.
Embodiment 3
A kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis that the present invention proposes, its raw material comprises by weight: 25.5 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 9.7 parts, Herba Rabdosiae Lophanthoidis 20.4 parts, Radix Curcumae 9.7 parts, Lignum et Radix Naucleae 10.3 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 14.3 parts, Herba Saxifragae przewalskii 6.7 parts, Pogonatum microstomum (schwaegr) Brid 5.5 parts, Rhizoma Corydalis 10.1 parts, 9.4 parts, Rhizoma Zingiberis Recens, 5.5 parts, Radix Glycyrrhizae.
Embodiment 4
A kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis that the present invention proposes, its raw material comprises by weight: 24.5 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 10.5 parts, Herba Rabdosiae Lophanthoidis 19.3 parts, Radix Curcumae 10.2 parts, Lignum et Radix Naucleae 9.2 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 15.6 parts, Herba Saxifragae przewalskii 5.2 parts, Pogonatum microstomum (schwaegr) Brid 6.3 parts, Rhizoma Corydalis 9.2 parts, 10.5 parts, Rhizoma Zingiberis Recens, 4.5 parts, Radix Glycyrrhizae.
Embodiment 5
A kind of Chinese medicine composition for the treatment of cholelithiasis and merging cholecystitis that the present invention proposes, its raw material comprises by weight: 25 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 10 parts, Herba Rabdosiae Lophanthoidis 20 parts, Radix Curcumae 10 parts, Lignum et Radix Naucleae 10 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 15 parts, Herba Saxifragae przewalskii 6 parts, Pogonatum microstomum (schwaegr) Brid 6 parts, Rhizoma Corydalis 10 parts, 10 parts, Rhizoma Zingiberis Recens, 5 parts, Radix Glycyrrhizae.
Select embodiment 5 to prepare medicament, three times on the one, each 10g two weeks is a course for the treatment of.Random selecting cholelithiasis merges cholecystitis case 100 example.After 4 courses for the treatment of, 51 examples of fully recovering altogether, effective 30 examples, effective 8 examples, invalid 11 examples.Cure rate of the present invention is 51%, and obvious effective rate is 30%, and effective percentage is 8%, and total effective rate is 89%, and inefficiency is 11%.
Curative effect determinate standard is as follows:
Recovery from illness: clinical symptoms and sign disappear completely, and gallbladder color ultrasound examination is normal;
Effective: clinical symptoms and sign disappear substantially, gallbladder color ultrasound examination meets effective standard;
Effective: clinical symptoms and sign major part disappear, and gallbladder color ultrasound examination reaches effective standard;
Invalid: clinical symptoms and sign are all not improved, even increase the weight of, gallbladder color ultrasound examination is without improvement.
The above; be only the present invention's preferably detailed description of the invention; but protection scope of the present invention is not limited thereto; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to according to technical scheme of the present invention and inventive concept thereof and replace or change, all should be encompassed within protection scope of the present invention.
Claims (4)
1. treat the Chinese medicine composition that cholelithiasis merges cholecystitis, it is characterized in that, its raw material comprises by weight: Pericarpium Citri Reticulatae Viride 24-26 part, Herba Taraxaci 9-11 part, Herba Rabdosiae Lophanthoidis 19-21 part, Radix Curcumae 9-11 part, Lignum et Radix Naucleae 9-11 part, Armillaria mella tabescens (Scop.ex Fr.) Sing. 14-16 part, Herba Saxifragae przewalskii 5-7 part, Pogonatum microstomum (schwaegr) Brid 5-7 part, Rhizoma Corydalis 9-11 part, Rhizoma Zingiberis Recens 9-11 part, Radix Glycyrrhizae 4-6 part.
2. treat the Chinese medicine composition that cholelithiasis merges cholecystitis according to claim 1, it is characterized in that, the weight ratio of Armillaria mella tabescens (Scop.ex Fr.) Sing., Herba Saxifragae przewalskii, Pogonatum microstomum (schwaegr) Brid, Rhizoma Corydalis and Rhizoma Zingiberis Recens is 14.3-15.6:5.2-6.7:5.5-6.3:9.2-10.1:9.4-10.5.
3. according to claim 1 or 2, treat the Chinese medicine composition that cholelithiasis merges cholecystitis, it is characterized in that, its raw material comprises by weight: Pericarpium Citri Reticulatae Viride 24.5-25.5 part, Herba Taraxaci 9.7-10.5 part, Herba Rabdosiae Lophanthoidis 19.3-20.4 part, Radix Curcumae 9.7-10.2 part, Lignum et Radix Naucleae 9.2-10.3 part, Armillaria mella tabescens (Scop.ex Fr.) Sing. 14.3-15.6 part, Herba Saxifragae przewalskii 5.2-6.7 part, Pogonatum microstomum (schwaegr) Brid 5.5-6.3 part, Rhizoma Corydalis 9.2-10.1 part, Rhizoma Zingiberis Recens 9.4-10.5 part, Radix Glycyrrhizae 4.5-5.5 part.
4. according to any one of claim 1-3, treat the Chinese medicine composition that cholelithiasis merges cholecystitis, it is characterized in that, its raw material comprises by weight: 25 parts, Pericarpium Citri Reticulatae Viride, Herba Taraxaci 10 parts, Herba Rabdosiae Lophanthoidis 20 parts, Radix Curcumae 10 parts, Lignum et Radix Naucleae 10 parts, Armillaria mella tabescens (Scop.ex Fr.) Sing. 15 parts, Herba Saxifragae przewalskii 6 parts, Pogonatum microstomum (schwaegr) Brid 6 parts, Rhizoma Corydalis 10 parts, 10 parts, Rhizoma Zingiberis Recens, 5 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410606877.5A CN104740558A (en) | 2014-10-31 | 2014-10-31 | Traditional Chinese medicine composition for treating gallstones with cholecystitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410606877.5A CN104740558A (en) | 2014-10-31 | 2014-10-31 | Traditional Chinese medicine composition for treating gallstones with cholecystitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104740558A true CN104740558A (en) | 2015-07-01 |
Family
ID=53581178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410606877.5A Pending CN104740558A (en) | 2014-10-31 | 2014-10-31 | Traditional Chinese medicine composition for treating gallstones with cholecystitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104740558A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105597052A (en) * | 2015-12-31 | 2016-05-25 | 王威 | Medicinal composition treating urinary calculus |
| CN106107036A (en) * | 2016-06-28 | 2016-11-16 | 宿松飞翔生态养殖有限公司 | A kind of livestock fodder additives with epidemic prevention function |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1781546A (en) * | 2004-11-30 | 2006-06-07 | 尹灵芝 | Recovery mixture for liver, gallbladder and stomach and its preparing method |
-
2014
- 2014-10-31 CN CN201410606877.5A patent/CN104740558A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1781546A (en) * | 2004-11-30 | 2006-06-07 | 尹灵芝 | Recovery mixture for liver, gallbladder and stomach and its preparing method |
Non-Patent Citations (2)
| Title |
|---|
| 李焕德等: "《临床基本药物手册》", 31 August 2014, 湖南科学技术出版社 * |
| 肖国士等: "《中医秘方全书（珍藏本）超值版》", 30 June 2012, 湖南科学技术出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105597052A (en) * | 2015-12-31 | 2016-05-25 | 王威 | Medicinal composition treating urinary calculus |
| CN106107036A (en) * | 2016-06-28 | 2016-11-16 | 宿松飞翔生态养殖有限公司 | A kind of livestock fodder additives with epidemic prevention function |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104042802A (en) | Traditional Chinese medicine composition capable of treating fatty liver | |
| CN103301267B (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
| CN110755542A (en) | Formula of uric acid-reducing gout-treating tea and preparation method thereof | |
| CN103860843A (en) | Chinese medicine ointment for treating psoriasis and preparation method thereof | |
| CN104740558A (en) | Traditional Chinese medicine composition for treating gallstones with cholecystitis | |
| CN105494781A (en) | Giant knotweed rhizome health care tea for reducing blood glucose and lowering blood lipid | |
| CN113876872A (en) | Formula for treating reflux esophagitis | |
| CN104001163B (en) | A kind of pharmaceutical composition treating infantile enteritis and preparation method thereof | |
| CN105125803A (en) | Traditional Chinese medicine used in radiology department and for preventing ographic contrast nephropathy, and preparation method | |
| CN106668409A (en) | Hui traditional Chinese medicine hedyotis diffusa willd anti-esophageal cancer oral liquid and preparation method thereof | |
| CN105726787A (en) | Traditional Chinese medicine enema for treating ulcerative colitis and preparing method of traditional Chinese medicine enema | |
| CN104645113A (en) | Traditional Chinese medicine preparation for treating nasopharyngeal carcinoma and preparation method of traditional Chinese medicine preparation | |
| CN103735906A (en) | Chinese herb preparation for treating dry bronchiectasis and preparation method thereof | |
| CN103860788A (en) | Traditional Chinese medicinal preparation for treating fatty liver and preparation method of traditional Chinese medicinal preparation | |
| CN104740374A (en) | Pharmaceutical composition for treating mild cholelithiasis | |
| CN107007697A (en) | One kind treats pelvic infecton or prostatitic Chinese medicine composition and its preparation | |
| CN107485699B (en) | Myrobalan antidiarrheal composition | |
| CN105412679A (en) | Traditional Chinese medicine preparation for treating lung abscess and preparation method thereof | |
| CN104825883A (en) | Traditional Chinese medicine prescription for treating rhinitis | |
| CN105031600A (en) | Suppository treating acute infantile diarrhea and preparation method thereof | |
| CN104888169A (en) | Traditional Chinese medicine for treating gastroparesis syndrome caused by diabetes | |
| CN104666663A (en) | Medicine for treating damp toxin immersed type edema and preparation method of medicine | |
| CN104435707A (en) | Pericarpium granati traditional Chinese medicine tea for prolonged diarrhea and dysentery and hemafecia and preparation method of pericarpium granati traditional Chinese medicine tea | |
| CN104740559A (en) | Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder | |
| CN103432416A (en) | Chinese herba preparation for treating children iron-deficiency anemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150701 |
|
| RJ01 | Rejection of invention patent application after publication |